Drug intelligence / Profile preview

human parathyroid hormone

Development stage
Unknown
Lead developer
Takeda
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Subcutaneous
01

Overview

Human parathyroid hormone (PTH) is a naturally occurring polypeptide hormone secreted by the parathyroid glands, playing a critical role in maintaining calcium and phosphate homeostasis in the blood. It acts on bones, kidneys, and indirectly on the small intestine to increase serum calcium levels. Therapeutically, recombinant forms and fragments of human parathyroid hormone are used as drugs. For instance, recombinant human parathyroid hormone is prescribed as an adjunct to calcium and vitamin D to manage hypocalcemia in patients with hypoparathyroidism. Its mechanism involves agonistic activity at the parathyroid hormone 1 receptor (PTH1R), which leads to increased renal calcium reabsorption, stimulation of calcium release from bone, and enhanced intestinal calcium absorption via activated vitamin D. One such recombinant product, Natpara, was approved but later faced manufacturing issues and its global manufacturing was discontinued. Another therapeutic form, teriparatide, a 1-34 fragment of PTH, is used in the treatment of osteoporosis.

Brand names
NatparaAdthyzaNiva ThyroidAPur ThyroidForteoBonsityPreotactYorvipath
Other names
parathormoneparathyrin
02

Targets

PTH1R (Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1)

Beyond the preview

Go deeper on human parathyroid hormone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human parathyroid hormone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call